Browse > Article
http://dx.doi.org/10.4070/kcj.2012.42.6.431

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter  

Chung, Han-Hee (Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea College of Medicine)
Moon, Keon-Woong (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine)
Jung, Mi-Hyang (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine)
Yang, Hae-Kyung (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine)
Park, Kyung-Seon (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine)
Yoo, Ki-Dong (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine)
Publication Information
Korean Circulation Journal / v.42, no.6, 2012 , pp. 431-433 More about this Journal
Abstract
Drug-eluting balloon (DEB) with angioplasty a paclitaxel-coated balloon catheter is an effective treatment option in patients with in-stent restenosis (ISR) after a drug-eluting stent (DES). We describe a case in which 'no-reflow' phenomenon developed after DEB angioplasty of a DES ISR lesion. Coronary flow was restored after intracoronary administration of nicorandil.
Keywords
Complications; Coronary restenosis; No-reflow phenomenon;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94.   DOI   ScienceOn
2 Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004;110:810-4.   DOI   ScienceOn
3 Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24.   DOI   ScienceOn
4 Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010;99:165-74.   DOI   ScienceOn
5 Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009;54:281-92.   DOI   ScienceOn
6 Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv 2008;72:950-7.   DOI   ScienceOn
7 Nakamura T, Brott BC, Brants I, et al. Vasomotor function after paclitaxel- coated balloon post-dilation in porcine coronary stent model. JACC Cardiovasc Interv 2011;4:247-55.   DOI   ScienceOn
8 Skalpe IO. The toxicity of non-ionic water-soluble monomeric and dimeric contrast media in selective vertebral angiography: an experimental study in rabbits. Neuroradiology 1983;24:219-23.   DOI   ScienceOn
9 Limbruno U, Petronio AS, Amoroso G, et al. The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media. Circulation 2000;101:491-7.   DOI   ScienceOn
10 Sakata Y, Kodama K, Ishikura F, et al. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction. Jpn Circ J 1997;61: 455-8.   DOI   ScienceOn
11 Iwakura K, Ito H, Okamura A, et al. Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis. Circ J 2009;73:925-31.   DOI   ScienceOn
12 Tsubokawa A, Ueda K, Sakamoto H, Iwase T, Tamaki S. Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy. Circ J 2002;66:1119-23.   DOI   ScienceOn